BINH DINH PHARMACEUTICAL AND MEDICAL EQUIPMENT |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40,550 VND | -1.10% |
|
-4.14% | -6.48% |
Valuation
| Fiscal Period: December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Capitalization 1 | 2,870,365 | 2,987,797 | 2,952,575 | 4,056,516 | 3,793,629 |
| Enterprise Value (EV) 1 | 2,870,365 | 2,987,797 | 2,952,575 | 4,056,516 | 3,793,629 |
| P/E ratio | 22.4 x | - | - | - | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 1.83 x | 1.9 x | 2.46 x | 2.06 x |
| EV / Revenue | - | 1.83 x | 1.9 x | 2.46 x | 2.06 x |
| EV / EBITDA | - | - | - | 11.8 x | 8.64 x |
| EV / FCF | - | - | 35,926,220 x | - | - |
| FCF Yield | - | - | 0% | - | - |
| Price to Book | - | - | 2.18 x | 2.83 x | 2.23 x |
| Nbr of stocks (in thousands) | 93,627 | 93,549 | 93,554 | 93,554 | 93,554 |
| Reference price 2 | 30,657 | 31,938 | 31,560 | 43,360 | 40,550 |
| Announcement Date | 3/30/20 | 1/27/22 | 1/31/23 | 1/26/24 | - |
1VND in Million2VND
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Net sales 1 | - | 1,634,684 | 1,554,817 | 1,651,770 | 1,844,000 |
| EBITDA 1 | - | - | - | 342,951 | 439,000 |
| EBIT 1 | - | - | 272,909 | 296,982 | 371,000 |
| Operating Margin | - | - | 17.55% | 17.98% | 20.12% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | 142,227 | 183,786 | - | - | - |
| Net margin | - | 11.24% | - | - | - |
| EPS | 1,367 | - | - | - | - |
| Free Cash Flow | - | - | 82,184 | - | - |
| FCF margin | - | - | 5.29% | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 3/30/20 | 1/27/22 | 1/31/23 | 1/26/24 | - |
1VND in Million2VND
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 Q3 |
|---|---|---|
| Net sales 1 | 414,094 | 444,495 |
| EBITDA | - | - |
| EBIT | - | - |
| Operating Margin | - | - |
| Earnings before Tax (EBT) | - | - |
| Net income | 71,830 | - |
| Net margin | 17.35% | - |
| EPS | - | - |
| Dividend per Share | - | - |
| Announcement Date | 7/25/23 | 1/26/24 |
1VND in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | 82,184 | - | - |
| ROE (net income / shareholders' equity) | - | - | 19.5% | 19.4% | 19.3% |
| ROA (Net income/ Total Assets) | - | - | 14.1% | 13.9% | 14.4% |
| Assets | - | - | - | - | - |
| Book Value Per Share 1 | - | - | 14,485 | 15,316 | 18,169 |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | 82,828 | - | - |
| Capex / Sales | - | - | 5.33% | - | - |
| Announcement Date | 3/30/20 | 1/27/22 | 1/31/23 | 1/26/24 | - |
1VND
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
40,550
VND
Average target price
48,000
VND
Spread / Average Target
+18.37%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.48% | 149M | |
| +20.39% | 43.67B | |
| +26.21% | 22.79B | |
| +21.32% | 15.45B | |
| +18.82% | 14.29B | |
| +53.37% | 12.83B | |
| -0.05% | 6.79B | |
| -11.88% | 6.52B | |
| -8.87% | 5.73B | |
| +12.62% | 5.59B |
- Stock Market
- Equities
- DBD Stock
- Financials Binh Dinh Pharmaceutical and Medical Equipment
